Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1.

ABSTRACT:

SUBMITTER: Zabriskie MS 

PROVIDER: S-EPMC4536190 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature